{"transactions":[{"id":1749943,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":108608,"kind":"person","name":"Diem Michael Craig","position":1,"cik":"0001497624","reported_name":"Diem Michael Craig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-03T20:04:27.000Z","date":"2023-11-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":20763,"price":1.49,"value":30936.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":253533,"source":{"system":"sec-edgar","filing":"0001062993-23-020089","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299323020089/form4.xml","form_type":"4"}},{"id":1889338,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":108608,"kind":"person","name":"Diem Michael Craig","position":1,"cik":"0001497624","reported_name":"Diem Michael Craig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-17T20:32:33.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":151058,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Century Therapeutic, Inc.'s (the \"Company's\") common stock. The RSUs shall vest 50% on November 1, 2023, with the remaining 50% vesting upon the earlier of: (i) November 1, 2024; and (ii) satisfaction of certain performance criteria, in each case subject to the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock."}],"balance_after":274296,"source":{"system":"sec-edgar","filing":"0001062993-23-011401","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299323011401/form4.xml","form_type":"4"}},{"id":2030766,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":108608,"kind":"person","name":"Diem Michael Craig","position":1,"cik":"0001497624","reported_name":"Diem Michael Craig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-06T23:49:24.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":131250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 25% on February 2, 2024, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":131250,"derivative":{"exercise_price":4.64,"expiration_date":"2033-02-02","underlying":"Common Stock","underlying_shares":131250},"source":{"system":"sec-edgar","filing":"0001062993-23-002307","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299323002307/form4.xml","form_type":"4"}},{"id":2030765,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":108608,"kind":"person","name":"Diem Michael Craig","position":1,"cik":"0001497624","reported_name":"Diem Michael Craig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-06T23:49:24.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":131250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 25% on February 2, 2024, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":131250,"derivative":{"exercise_price":4.64,"expiration_date":"2033-02-02","underlying":"Common Stock","underlying_shares":131250},"source":{"system":"sec-edgar","filing":"0001062993-23-002307","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299323002307/form4.xml","form_type":"4"}},{"id":2030764,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":108608,"kind":"person","name":"Diem Michael Craig","position":1,"cik":"0001497624","reported_name":"Diem Michael Craig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-02-06T23:49:24.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":21875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Century Therapeutic, Inc.'s (the \"Company's\") common stock. The RSUs vest 25% on February 2, 2024 and the remaining 75% vest on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock."}],"balance_after":123238,"source":{"system":"sec-edgar","filing":"0001062993-23-002307","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299323002307/form4.xml","form_type":"4"}},{"id":2030763,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":108608,"kind":"person","name":"Diem Michael Craig","position":1,"cik":"0001497624","reported_name":"Diem Michael Craig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-02-06T23:49:24.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":21875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Century Therapeutic, Inc.'s (the \"Company's\") common stock. The RSUs vest 25% on February 2, 2024 and the remaining 75% vest on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock."}],"balance_after":101363,"source":{"system":"sec-edgar","filing":"0001062993-23-002307","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299323002307/form4.xml","form_type":"4"}},{"id":2424122,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":108608,"kind":"person","name":"Diem Michael Craig","position":1,"cik":"0001497624","reported_name":"Diem Michael Craig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-27T21:51:27.000Z","date":"2022-01-25","kind":"grant","acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on January 25, 2023, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":105000,"derivative":{"exercise_price":13.15,"expiration_date":"2032-01-25","underlying":"Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001062993-22-001691","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299322001691/form4.xml","form_type":"4"}}]}